At the end of the latest market close, Timber Pharmaceuticals, Inc. (TMBR) was valued at $2.19. In that particular session, Stock kicked-off at the price of $2.18 while reaching the peak value of $2.24 and lowest value recorded on the day was $2.1. The stock current value is $2.22.
Timber Pharmaceuticals, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.60 on 01/27/20, with the lowest value was $1.90 for the same time period, recorded on 06/15/20.
Timber Pharmaceuticals, Inc. (TMBR) full year performance was -68.98%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Timber Pharmaceuticals, Inc. shares are logging -82.38% during the 52-week period from high price, and 16.84% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.90 and $12.60.
The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 389354 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Timber Pharmaceuticals, Inc. (TMBR) recorded performance in the market was -56.37%, having the revenues showcasing -37.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 27.17M, as it employees total of 3 workers.
Analysts verdict on Timber Pharmaceuticals, Inc. (TMBR)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.82, with a change in the price was noted -2.91. In a similar fashion, Timber Pharmaceuticals, Inc. posted a movement of -56.76% for the period of last 100 days, recording 492,932 in trading volumes.
Timber Pharmaceuticals, Inc. (TMBR): Technical Analysis
Raw Stochastic average of Timber Pharmaceuticals, Inc. in the period of last 50 days is set at 3.75%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 22.22%. In the last 20 days, the company’s Stochastic %K was 22.45% and its Stochastic %D was recorded 22.15%.
Let’s take a glance in the erstwhile performances of Timber Pharmaceuticals, Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -56.37%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -51.32%, alongside a downfall of -68.98% for the period of the last 12 months. The shares increased approximately by 3.99% in the 7-day charts and went up by -1.77% in the period of the last 30 days. Common stock shares were lifted by -37.48% during last recorded quarter.